Ai-Driven Diagnosis Of Non-Alcoholic Fatty Liver Disease And Associated Comorbidities

Non-alcoholic fatty liver disease (NAFLD) is a globally prevalent hepatic condition caused by the buildup of fat in the liver. It is frequently associated with metabolic comorbidities such as hypertension, cardiovascular disease (CVD), and prediabetes. However, early detection remains challenging due to the asymptomatic progression, and existing primary diagnostic methods, such as imaging or liver biopsy, are often expensive and inaccessible in rural areas. This study proposes a two-stage, interpretable machine learning pipeline for the non-invasive and cost-effective prediction of NAFLD and its key comorbidities using routine clinical parameters. The NAFLD prediction model was developed using the XGBoost algorithm, trained on a hybrid dataset that combines real patient data with rule-based synthetic data generated by simulating clinically plausible cases. Upon NAFLD-positive prediction, three separate XGB models, trained on data labelled based on thresholds, assess individual risks for hypertension, cardiovascular disease, and prediabetes. Explainability is obtained using SHAP (SHapley Additive exPlanations), which provides insight into feature relevance, while biomarker radar plots help in the visual interpretation of comorbidities. A user-friendly Streamlit interface enables real-time interaction with the tool for potential clinical application. The NAFLD model demonstrated robust performance, while the models used for predicting comorbidities achieved perfect performance, which may be a reflection of the limited dataset size used in the second stage. This work underscores the potential of AI-driven tools in NAFLD diagnosis, particularly when combined with explainable AI methods.